Oral Premalignant Lesions Chromosome Polysomy and Histological Characteristics in Updated

Head and neck tumorigenesis has been postulated to represent a multistep process driven by the accumulation of carcinogen-induced genetic changes throughout the exposed tissue field. To better explore this genetic instability process at the tissue level, 59 regions within 26 biopsy tissue specimens from individuals with oral leukoplakia have been subjected to chromosome 9 in situ hybridization analysis, and the degree of chromosome instability was related to known clinical/pathological parameters associated with tumor risk. Whereas chromosome indices were similar between high-risk lesion sites and low-risk lesion sites, high-risk lesions showed higher levels of chromosome polysomy than did low-risk sites [median PIs (polysomy indices), 2.1versus1.4, respectively]. Similarly, dysplastic regions showed significantly higher chromosome polysomy levels than hyperplastic regions (median PIs, 2.4versus1.5, respectively). Interestingly, however, hyperplastic regions in the same biopsy as dysplastic regions showed two-times higher polysomy levels than those in biopsies without dysplasia (median PIs, 2.6versus1.3, respectively), suggesting that chromosome polysomy determinations provide a field measurement for the degree of ongoing genetic insult. Finally, chromosome polysomy tended to persist or increase in the superficial epithelial layers in regions showing koilocytosis, whereas their frequency decreased in nonkoilocytotic regions, suggesting that epigenetic factors may serve to perpetuate the levels of genetically unstable cells in the epithelium. These results provide direct support for the field cancerization process and suggest that measurements of genetic instability might provide additional biological information beyond histology and lesion site characteristics in the assessment of head and neck cancer risk.

[1]  K. Münger,et al.  The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[3]  K. Münger,et al.  Association of human papillomaviruses with a subgroup of head and neck squamous cell carcinomas. , 2000, Journal of the National Cancer Institute.

[4]  S. Lippman,et al.  Predicting cancer development in oral leukoplakia: ten years of translational research. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[6]  D. Brash,et al.  Sunlight and the onset of skin cancer. , 1997, Trends in genetics : TIG.

[7]  K. Münger,et al.  The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. , 1997, Genes & development.

[8]  B. Stillman,et al.  Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. , 1997, Genes & development.

[9]  D. Wazer,et al.  E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. , 1996, Cancer research.

[10]  L. Banks,et al.  HPV-18 E6 mediated inhibition of p53 DNA binding activity is independent of E6 induced degradation. , 1995, Oncogene.

[11]  W. Hong,et al.  Biomarkers in upper aerodigestive tract tumorigenesis: a review. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  G. Hortobagyi,et al.  Quantitative analysis of chromosome in situ hybridization signal in paraffin-embedded tissue sections. , 1994, Cytometry.

[13]  W. Hong,et al.  Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. , 1994, Cancer research.

[14]  S. Lippman,et al.  Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion. , 1993, Journal of the National Cancer Institute.

[15]  J. Milner,et al.  Targeting and degradation of p53 by E6 of human papillomavirus type 16 is preferential for the 1620+ p53 conformation. , 1993, Oncogene.

[16]  D. Housman,et al.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.

[17]  W. Hong,et al.  Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. , 1993, Cancer research.

[18]  D. Lydall,et al.  Cell cycle checkpoints, genetic instability and cancer. , 1993, Seminars in cancer biology.

[19]  S. Lippman,et al.  Head and Neck Cancer , 1993, Cancer Treatment and Research.

[20]  J. Garlick,et al.  Human papillomavirus infection of the oral mucosa. , 1991, The American Journal of dermatopathology.

[21]  L. Loeb,et al.  Mutator phenotype may be required for multistage carcinogenesis. , 1991, Cancer research.

[22]  S. Dawsey,et al.  Validation of intermediate end points in cancer research. , 1990, Journal of the National Cancer Institute.

[23]  F. Meyskens,et al.  Coming of age--the chemoprevention of cancer. , 1990, The New England journal of medicine.

[24]  A. Levine,et al.  Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.

[25]  S. Lippman,et al.  Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. , 1989, International journal of radiation oncology, biology, physics.

[26]  I. van der Waal,et al.  Oral leukoplakia, with emphasis on malignant transformation. A follow-up study of 46 patients. , 1989, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[27]  M. Zelen,et al.  Are primary cancer prevention trials feasible? , 1988, Journal of the National Cancer Institute.

[28]  P. Lind,et al.  Malignant transformation in oral leukoplakia. , 1987, Scandinavian journal of dental research.

[29]  E. Farber.  The multistep nature of cancer development. , 1984, Cancer research.

[30]  M. Gorsky,et al.  Oral leukoplakia and malignant transformation. A follow‐up study of 257 patients , 1984, Cancer.

[31]  I. Kramer,et al.  The clinical features and risk of malignant transformation in sublingual keratosis , 1978, British Dental Journal.

[32]  W. G. Shafer,et al.  Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias , 1975, Cancer.

[33]  D. Slaughter,et al.  “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.

[34]  S. Lippman,et al.  Detection of chromosome instability of tissue fields at risk: In situ hybridization , 1996, Journal of cellular biochemistry. Supplement.

[35]  E. White,et al.  Life, death, and the pursuit of apoptosis. , 1996, Genes & development.

[36]  S. Lippman,et al.  p53 and retinoid chemoprevention of oral carcinogenesis. , 1995, Cancer research.

[37]  S. Lippman,et al.  Cancer chemoprevention. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  W. Hittelman,et al.  Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization. Mapping genotype/phenotype heterogeneity. , 1993, The American journal of pathology.

[39]  C. Boone,et al.  Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. , 1990, Cancer research.

[40]  J. Regezi,et al.  Oral pathology: Clinical-pathologic correlations , 1989 .

[41]  L. Sobin,et al.  Definition of leukoplakia and related lesions: an aid to studies on oral precancer. , 1978, Oral surgery, oral medicine, and oral pathology.